Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices. (3rd June 2022)

• Record Type: Journal Article
• Authors: Zhang, Cheng-Wu; Zhang, Jun-Gang; Yang, Xue; Du, Wen-Lin; Yu, Zi-Lin; Lv, Zhen-Ye; Mou, Xiao-Zhou
• Is Part Of: Expert opinion on drug delivery. Volume 19:Number 6(2022)
• Page Start: 623
• Page End: 640
• Publication Date: 2022-06-03
• Subjects: Carbohydrates -- nanomaterials -- cancer -- stimulus-responsive -- nanocarriers -- chemotherapy; Drug delivery devices -- Periodicals; Drug delivery systems -- Periodicals; 615.605
• DOI: 10.1080/17425247.2022.2081320
• Languages: English
• ISSNs: 1742-5247

Abstract

ABSTRACT: Introduction: Many nanocarriers have been developed to react physicochemically to exterior stimuli like ultrasonic, light, heat, and magnetic fields, along with various internal stimuli including pH, hypoxia, enzyme, and redox potential. Nanocarriers are capable to respond various stimuli within the cancer cells to enable on-demand drug delivery, activation of bioactive compounds, controlled drug release, and targeting ligands, as well as size, charge, and conformation conversion, enabling sensing and signaling, overcoming multidrug resistance, accurate diagnosis, and precision therapy. Areas covered: Carbohydrates are ubiquitous biomolecules with a high proclivity for supramolecular network formation. Numerous carbohydrate-based nanomaterials have been used in biological solicitations and stimuli-based responses. Particular emphasis has been placed on the utilization of carbohydrate-based NPs and nanogels in various fields including imaging, drug administration, and tissue engineering. Because the assembly process is irreversible, carbohydrate-based systems are excellent ingredients for the development of stimulus-responsive nanocarriers for cancer-targeted chemotherapy. This review aims to summarise current research on carbohydrate-based nanomaterials, with an emphasis on stimuli-sensitive nanocarriers for cancer-targeted chemotherapy. Expert opinion: Carbohydrates-based stimulus-responsive nanomaterials have been proved highly efficient for targeted delivery of anticancer drugs, thus leading to effective chemotherapy with minimum off-target effects.